Virus Associated Hemophagocytic Syndrome Overview

Save information for later
Sign Up

Learn About Virus Associated Hemophagocytic Syndrome

What is the definition of Virus Associated Hemophagocytic Syndrome?
Virus associated hemophagocytic syndrome is a very serious complication of a viral infection. Signs and symptoms of Virus associated hemophagocytic syndrome, include high fever, liver problems, enlarged liver and spleen, coagulation factor abnormalities, decreased red or white blood cells and platelets (pancytopenia), and a build-up of histiocytes, a type of immune cell, in various tissues in the body resulting in the destruction of blood-producing cells (histiocytic proliferation with prominent hemophagocytosis). Diagnosis is based upon the signs and symptoms of the patient. The cause of the condition is not known.
Who are the top Virus Associated Hemophagocytic Syndrome Local Doctors?
Distinguished in Virus Associated Hemophagocytic Syndrome
Dr. Muhamed Baljevic
Hematology Oncology | Hematology | Oncology
Distinguished in Virus Associated Hemophagocytic Syndrome
Dr. Muhamed Baljevic
Hematology Oncology | Hematology | Oncology

Vanderbilt Health Clinicians, LLC

3601 The Vanderbilt Clinic, 
Nashville, TN 
615-322-3000
Languages Spoken:
English, Bosnian, Tibetan Standard
See accepted insurances
Accepting New Patients
Offers Telehealth

Muhamed Baljevic is a Hematologist Oncology specialist and a Hematologist in Nashville, Tennessee. Dr. Baljevic is rated as a Distinguished provider by MediFind in the treatment of Virus Associated Hemophagocytic Syndrome. His top areas of expertise are Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Smoldering Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Baljevic is currently accepting new patients.

Scott S. Smith
Experienced in Virus Associated Hemophagocytic Syndrome
Dr. Scott S. Smith
Hematology Oncology | Oncology
Experienced in Virus Associated Hemophagocytic Syndrome
Dr. Scott S. Smith
Hematology Oncology | Oncology

Duke Cancer Center Raleigh

3404 Wake Forest Rd, 
Raleigh, NC 
919-862-5970
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Scott Smith is a Hematologist Oncology specialist and an Oncologist in Raleigh, North Carolina. Dr. Smith is rated as an Experienced provider by MediFind in the treatment of Virus Associated Hemophagocytic Syndrome. His top areas of expertise are Lung Cancer, Familial Colorectal Cancer, Hodgkin Lymphoma, and Paget Disease of the Breast. Dr. Smith is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Advanced in Virus Associated Hemophagocytic Syndrome
Dr. Zaid S. Al-Kadhimi
Hematology | Oncology | Hematology Oncology
Advanced in Virus Associated Hemophagocytic Syndrome
Dr. Zaid S. Al-Kadhimi
Hematology | Oncology | Hematology Oncology

University Of Alabama Health Services Foundation, PC

619 19th St S, 
Birmingham, AL 
205-934-3460
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Zaid Al-Kadhimi is a Hematologist and an Oncologist in Birmingham, Alabama. Dr. Al-Kadhimi is rated as an Advanced provider by MediFind in the treatment of Virus Associated Hemophagocytic Syndrome. His top areas of expertise are Acute Myeloid Leukemia (AML), Graft Versus Host Disease (GvHD), Myelodysplastic Syndrome (MDS), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Al-Kadhimi is currently accepting new patients.

View All Doctors
What are the latest Virus Associated Hemophagocytic Syndrome Clinical Trials?
Open-Label Individual Patient Study of Epstein-Barr Virus (EBV) Specific T-Cell Lines for the Treatment of a Lymphoproliferative Disease and Hemophagocytic Syndrome Associated With EBV
Open-Label Individual Patient Study of Epstein-Barr Virus (EBV) Specific T-Cell Lines for the Treatment of a Lymphoproliferative Disease and Hemophagocytic Syndrome Associated With EBV
Enrollment Status: Recruiting
Publish Date: April 30, 2024
Intervention Type: Biological
Study Phase: Not Applicable

Summary: Single-patient trial aiming to provide immunological consolidation following allogeneic stem cell transplantation to a young adult patient suffering from a systemic EBV-positive lymphoma of childhood.

Match to trials
Find the right clinical trials for you in under a minute
Get started
View All Clinical Trials
Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center